… to III HER2-positive breast cancer, outperforming HR status … HER2-positive (ERBB2+) breast cancer at Catalan Institute … before the initiation of paclitaxel. Following neoadjuvant therapy … positive breast cancer treated with 15 weeks of neoadjuvant paclitaxel, …

… complete response (pCR) in breast cancer patients undergoing neoadjuvant chemotherapy. … 5); and doxorubicin, cyclophosphamide, and paclitaxel (n = 1). Following therapy, … composition and pCR in breast cancer patients undergoing neoadjuvant chemotherapy. …

… new treatment for triple-negative breast cancer (TNBC) that tackles … chemotherapy drugs such as paclitaxel and currently cannot be … it often becomes resistant to paclitaxel, causing the survival rate … when used in combination with paclitaxel, he added. The …

… ER+/PR-) breast cancers. This comprehensive investigation, … chemotherapeutics like docetaxel, paclitaxel, and vinorelbine, … hormone receptor-positive breast cancer patients undergoing neoadjuvant … biology. As breast cancer management advances towards …

… of multidrug-resistant breast cancer. The mechanism involves … Human breast cancer cell (MCF-7) and breast cancer resistance … and multidrug-resistant breast cancer cells. Furthermore, … D. Paclitaxel’s mechanistic and clinical effects on breast cancer. …

… been a great year for breast cancer, with new data that should … ;s choice of chemotherapy, either paclitaxel or the combination of gemcitabine … days for our patients with breast cancer.  Thank you, again, for joining …

… with triple-negative breast cancer and hormone receptor … for metastatic triple-negative breast cancer [TNBC]? Gandhi … ) regimen of pembrolizumab, paclitaxel, and carboplatin], how would … chemoimmunotherapy for triple-negative breast cancer (TNBC).J Clin …

… a history of breast cancer. Breast cancer and CVD share … Approximately 15% of breast cancers overexpress HER2 and … -negative breast cancer when added to neoadjuvant paclitaxel and … venous thromboembolism in breast cancer survivors. Breast Cancer Res Treat. …

… the HER2-positive breast cancer landscape has demonstrated … ). In patients whose breast tumors and nodes were examined … in the HER2-positive breast cancer space, including monoclonal … with paclitaxel plus trastuzumab in HER2-positive breast cancer have …

… the treatment of breast cancer. This molecule, named … Paclitaxel, noting that initial lab tests demonstrate similar efficacy in eradicating breast cancer … without harming animals. Breast cancer remains the most … the treatment of breast cancer. News world This …